On the contrary, in malignant peripheral nerve sheath tumors (MPNSTs), head and neck squamous cell carcinoma, and esophageal squamous cell carcinoma, CRABP2 exert a tumor-inhibiting effect [14,15,16]. Here, CRABP2 is linked to head and neck squamous cell carcinoma.